Geode Capital Management LLC lifted its stake in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,054,162 shares of the company’s stock after purchasing an additional 16,065 shares during the quarter. Geode Capital Management LLC owned about 2.29% of Avanos Medical worth $25,337,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Quarry LP purchased a new stake in Avanos Medical in the 3rd quarter worth about $42,000. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after buying an additional 1,095 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Avanos Medical in the second quarter worth approximately $70,000. XTX Topco Ltd purchased a new stake in shares of Avanos Medical in the second quarter worth approximately $202,000. Finally, Intech Investment Management LLC bought a new stake in shares of Avanos Medical during the 3rd quarter worth approximately $207,000. Institutional investors own 95.17% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.
Avanos Medical Trading Down 1.5 %
AVNS stock opened at $15.92 on Friday. Avanos Medical, Inc. has a 12 month low of $15.77 and a 12 month high of $25.36. The firm’s 50-day moving average is $19.14 and its 200 day moving average is $21.19. The company has a market capitalization of $731.64 million, a PE ratio of 46.82 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
See Also
- Five stocks we like better than Avanos Medical
- Investing In Preferred Stock vs. Common Stock
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How AI Implementation Could Help MongoDB Roar Back in 2025
- How to Find Undervalued Stocks
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.